TC BioPharm (Holdings) plc - Warrants
Share · US87807D1110 · TCBPW (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of TC BioPharm (Holdings) plc - Warrants
No Price
Company Profile for TC BioPharm (Holdings) plc - Warrants Share
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its products pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; ImmuniStim, an unmodified cell therapy to treat COVID-19; TCB009 for the GI-tract cancer treatment; and TCB005/TCB006 that are allogeneic co-stimulatory GD-T CAR pre-clinical drug candidates would target antigens expressed on various solid tumor types. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
Company Data
Name TC BioPharm (Holdings) plc - Warrants
Company TC Biopharm (Holdings) Plc
Symbol TCBPW
Website
https://www.tcbiopharm.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US87807D1110
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Bryan Leland Kobel
Country United Kingdom
Currency USD
Employees 0,0 T
Address Maxim 1, ML1 4WR Motherwell
Stock Splits
| Date | Split |
|---|---|
| 21.11.2022 | 1:50 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | TCBPW |
More Shares
Investors who hold TC BioPharm (Holdings) plc - Warrants also have the following shares in their portfolio:
